Discovery: Leverage Intelligence
Quickly solving a problem. Using real-life health related data to inform strategy. Shift from planning assumptions to real-life intelligence – powered by behavior, sentiment and engagement data.
How Agencies Use Advanced Data Science and AI for their 2026 Brand Plans
Sign Up to Stay Ahead of Message Impact
Discover how Pharma marketeers are finally measuring which messages change HCP behavior. Our newsletter shares evidence-led insights powered by DrugVoice and the Message Resonance Score™ so you can predict and prove message impact—before prescriptions are written.
Inside This Session
If you’re focused on retaining and growing your Pharma clients in 2026, building smarter brand plans is critical. That means going beyond the pitch and delivering strategic value throughout the year.
In this session, we’ll talk to the importance of HCP intelligence and how Talking Medicines Advanced Data Science and AI supports Agencies like yours across the full brand lifecycle. Watch now to learn more.
More from The Talking Room
Large Language Models and Regulatory-Grade GLP-1 Content: Challenges and the Need for Accurate Message Measurement
Can large language models truly support regulatory-grade pharmaceutical communication? Learn more in our recent TMLabs briefing session.
Introducing DrugVoice
DrugVoice turns unstructured HCP data into Predictive HCP Intelligence, revealing how scientific messaging lands and influences HCP behavior.